Supply of Labetalol Hydrochloride Injection (Pharmaceutical Product)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The contract involves the supply and delivery of two vials of Labetalol Hydrochloride Injection, a pharmaceutical product required to meet strict FDA and USP standards for quality, purity, and safety. The product must be accurately labeled and securely packaged to ensure safe transportation and integrity upon receipt. This is a subcontract under the broader procurement efforts of the Defense Logistics Agency, a division of the Department of Defense, indicating the product is intended for military or federal healthcare use. The NAICS code 325412 confirms the manufacturing classification as pharmaceutical preparation. The contract was posted on July 17, 2026, and is linked to the award SPE2DX25D8022 with delivery order SPE2D926F7420, though specific performance location and point of contact details are not provided.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
